AR006523A1 - Compuestos ciclicos, inhibidores de la adhesion - Google Patents
Compuestos ciclicos, inhibidores de la adhesionInfo
- Publication number
- AR006523A1 AR006523A1 ARP970101342A ARP970101342A AR006523A1 AR 006523 A1 AR006523 A1 AR 006523A1 AR P970101342 A ARP970101342 A AR P970101342A AR P970101342 A ARP970101342 A AR P970101342A AR 006523 A1 AR006523 A1 AR 006523A1
- Authority
- AR
- Argentina
- Prior art keywords
- phe
- alkyl
- atoms
- substituted
- gly
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 150000001923 cyclic compounds Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000006495 integrins Human genes 0.000 abstract 2
- 108010044426 integrins Proteins 0.000 abstract 2
- 102000001189 Cyclic Peptides Human genes 0.000 abstract 1
- 108010069514 Cyclic Peptides Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000002491 angiogenic effect Effects 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
El campo de aplicación es la medicina, en particular la inhibición de las integrinas. Se proponen péptidos cíclicos de fórmula (I): ciclo-(Arg-Gly-Asp-X-Y), en la que X es Cha, Nal, Phe, 2-R1-Phe, 3-R1-Phe, 4-R1-Phe, homo-Phe, Phg,T hi, Trp, Tyr o derivados de Tyr, donde el grupo OHpuede encontrarse eterificado con restos de alquilo de 1 a 18 átomos de C, pudiendo tratarse, además, de derivados de dichos aminoácidos; R1 es NH2, NO2,I, Br, Cl, F, alquilo de 1 a 18 átomosde C, Ar, Ar-O o 3H; Y es Gly, donde el N en posición alfa puede estar sustituido con R2, y/o el C en posiciónalfa puede esta sustituido con R3 y/o R4, con la condición de que Gly ha de estar sustituido al menos una vez del modo indicado; Ares feniloeventualmente sustituido una o dos veces con NH2, NO2, I, Br, Cl, F, alquilo de 1 a 6 átomos de C o 3H; R2, R3 o R4 son alquilo de 1 a 18 átomos de C,o bien R2 junto con R3 y R3 junto con R4 son una cadena de alquileno. Estoscompuestos acuan como inhibidores de las integrinas y se pueden emplear enparticular para prevenir y tratar enfermedades del sistema circulatorio, enfermedades angiogénicas, infecciones microbianas y para el tratamaiento detumores.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19613933A DE19613933A1 (de) | 1996-04-06 | 1996-04-06 | Cyclische Adhäsionsinhibitoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR006523A1 true AR006523A1 (es) | 1999-09-08 |
Family
ID=7790744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970101342A AR006523A1 (es) | 1996-04-06 | 1997-04-04 | Compuestos ciclicos, inhibidores de la adhesion |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6127335A (es) |
| EP (1) | EP0904285B1 (es) |
| JP (1) | JP4115530B2 (es) |
| KR (1) | KR100438378B1 (es) |
| CN (1) | CN1119351C (es) |
| AR (1) | AR006523A1 (es) |
| AT (1) | ATE224402T1 (es) |
| AU (1) | AU717496B2 (es) |
| BR (1) | BR9708530A (es) |
| CA (1) | CA2250861C (es) |
| CZ (1) | CZ291510B6 (es) |
| DE (2) | DE19613933A1 (es) |
| DK (1) | DK0904285T3 (es) |
| ES (1) | ES2183159T3 (es) |
| HU (1) | HUP9903631A3 (es) |
| NO (1) | NO984667L (es) |
| PL (1) | PL187924B1 (es) |
| PT (1) | PT904285E (es) |
| RU (1) | RU2184121C2 (es) |
| SK (1) | SK283718B6 (es) |
| TW (1) | TW570929B (es) |
| UA (1) | UA61071C2 (es) |
| WO (1) | WO1997038009A1 (es) |
| ZA (1) | ZA972843B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| IL143901A0 (en) | 1998-12-23 | 2002-04-21 | Searle & Co | Use of cyclooxygenase-2- inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| US6858598B1 (en) | 1998-12-23 | 2005-02-22 | G. D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| US6521593B1 (en) * | 1999-02-01 | 2003-02-18 | Childrens Hospital Los Angeles | Methods for inhibiting brain tumor growth |
| UA71608C2 (en) | 1999-03-11 | 2004-12-15 | Merck Patent Gmbh | A method for producing the cyclic pentapeptide |
| SK5902003A3 (en) | 2000-11-01 | 2003-08-05 | Merck Patent Gmbh | Methods and compositions for the treatment of diseases of the eye |
| UA75898C2 (en) * | 2000-11-14 | 2006-06-15 | Merck Patent Gmbh | Method for prophylaxis and treatment of eye diseases using antagonist of integrin receptors |
| JP4499327B2 (ja) * | 2001-12-06 | 2010-07-07 | 松崎 浩巳 | 拡径器具および手術器具セット |
| JP2005533001A (ja) * | 2002-03-04 | 2005-11-04 | メディミューン，インコーポレーテッド | インテグリンαｖβ３アンタゴニストを他の物質と併用投与する癌の予防または治療方法 |
| JP2005525368A (ja) * | 2002-03-04 | 2005-08-25 | メディミューン，インコーポレーテッド | インテグリンαｖβ３アンタゴニストをＨＭＧ−ＣｏＡ還元酵素阻害剤またはビスフォスフォネートと併用投与する障害の予防または治療方法 |
| AU2003218110A1 (en) | 2002-03-12 | 2003-09-29 | Bristol-Myers Squibb Company | C3-cyano epothilone derivatives |
| ITRM20020402A1 (it) * | 2002-07-29 | 2004-01-29 | Sigma Tau Ind Farmaceuti | Derivati fluoro-alchil-ciclopeptidi ad attivita' anti-integrine. |
| US20040224986A1 (en) | 2002-08-16 | 2004-11-11 | Bart De Corte | Piperidinyl targeting compounds that selectively bind integrins |
| US20040077684A1 (en) * | 2002-08-16 | 2004-04-22 | Bart De Corte | Piperidinyl compounds that selectively bind integrins |
| RU2234331C1 (ru) * | 2002-12-30 | 2004-08-20 | Смирнов Алексей Владимирович | Лекарственное средство |
| WO2004066956A2 (en) * | 2003-01-30 | 2004-08-12 | Medimmune, Inc. | Uses of integrin alphavbeta3 antagonists |
| CN101990425B (zh) * | 2008-04-08 | 2016-01-20 | 默克专利股份有限公司 | 包含环肽的组合物和使用方法 |
| US10745444B2 (en) * | 2017-04-17 | 2020-08-18 | National Tsing Hua University | Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same |
| EP3392262B1 (en) * | 2017-04-17 | 2021-08-18 | National Tsing Hua University | Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same |
| US10494403B2 (en) | 2018-03-06 | 2019-12-03 | Ciphore Biomed Technology Limited Company | Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT89279B (pt) * | 1987-12-21 | 1993-08-31 | Sandoz Sa | Processo para a preparacao de uma nova forma cristalina de ciclosporinas e de composicoes farmaceuticas que as contem |
| CN1077279A (zh) * | 1992-04-09 | 1993-10-13 | 北京矿冶研究总院 | 雷管桥丝发火电阻安全检测仪 |
| UA43823C2 (uk) * | 1992-07-06 | 2002-01-15 | Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг | ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН |
| AU5978594A (en) * | 1993-02-04 | 1994-08-29 | Banyu Pharmaceutical Co., Ltd. | Novel cyclic pentapeptide |
| DE4310643A1 (de) * | 1993-04-01 | 1994-10-06 | Merck Patent Gmbh | Cyclische Adhäsionsinhibitoren |
| DE19534177A1 (de) * | 1995-09-15 | 1997-03-20 | Merck Patent Gmbh | Cyclische Adhäsionsinhibitoren |
-
1996
- 1996-04-06 DE DE19613933A patent/DE19613933A1/de not_active Withdrawn
-
1997
- 1997-02-04 UA UA98105792A patent/UA61071C2/uk unknown
- 1997-04-02 RU RU98120600/04A patent/RU2184121C2/ru active
- 1997-04-02 JP JP53581497A patent/JP4115530B2/ja not_active Expired - Lifetime
- 1997-04-02 CA CA002250861A patent/CA2250861C/en not_active Expired - Fee Related
- 1997-04-02 AT AT97917291T patent/ATE224402T1/de active
- 1997-04-02 DE DE59708269T patent/DE59708269D1/de not_active Expired - Lifetime
- 1997-04-02 CZ CZ19983203A patent/CZ291510B6/cs not_active IP Right Cessation
- 1997-04-02 BR BR9708530A patent/BR9708530A/pt not_active Application Discontinuation
- 1997-04-02 ES ES97917291T patent/ES2183159T3/es not_active Expired - Lifetime
- 1997-04-02 CN CN97194526A patent/CN1119351C/zh not_active Expired - Lifetime
- 1997-04-02 DK DK97917291T patent/DK0904285T3/da active
- 1997-04-02 PT PT97917291T patent/PT904285E/pt unknown
- 1997-04-02 HU HU9903631A patent/HUP9903631A3/hu unknown
- 1997-04-02 KR KR10-1998-0707888A patent/KR100438378B1/ko not_active Expired - Fee Related
- 1997-04-02 PL PL32915497A patent/PL187924B1/pl not_active IP Right Cessation
- 1997-04-02 WO PCT/EP1997/001657 patent/WO1997038009A1/de not_active Ceased
- 1997-04-02 EP EP97917291A patent/EP0904285B1/de not_active Expired - Lifetime
- 1997-04-02 SK SK1364-98A patent/SK283718B6/sk unknown
- 1997-04-02 AU AU25688/97A patent/AU717496B2/en not_active Ceased
- 1997-04-02 US US09/155,721 patent/US6127335A/en not_active Expired - Lifetime
- 1997-04-03 ZA ZA9702843A patent/ZA972843B/xx unknown
- 1997-04-04 AR ARP970101342A patent/AR006523A1/es not_active Application Discontinuation
- 1997-07-08 TW TW086104359A patent/TW570929B/zh active
-
1998
- 1998-10-06 NO NO984667A patent/NO984667L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR006523A1 (es) | Compuestos ciclicos, inhibidores de la adhesion | |
| NO2014010I1 (no) | Radium 223 salt slik som Radium 223 diklorid | |
| EA200200208A1 (ru) | Синергитическая композиция | |
| AR020062A1 (es) | Una composicion farmaceutica solida o semisolida para la liberacion sostenida de peptidos | |
| NO994409L (no) | Stabilisering av syresensitive benzimidazoler med aminosyre/cyklodekstrin-kombinasjoner | |
| ATE249214T1 (de) | Pentafluorobenzensulfonamide und analoge | |
| EA200000994A1 (ru) | Применение кабэрголина при лечении синдрома усталых ног | |
| BR0215240A (pt) | Derivados de calcona e seu uso no tratamento de doenças | |
| BRPI0110024B8 (pt) | derivados de ecteinascidina antitumorais, composição farmacêutica que os compreende e uso dos mesmos | |
| TR199802534T2 (xx) | Leptin (OB Protein) fragmanlar� | |
| NO990522D0 (no) | Anvendelse av <beta>-ark mimetika som protease- og kinaseinhibatorer av transkripsjonsfaktorer | |
| DE69116380D1 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
| ATE201597T1 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
| PT1157030E (pt) | Complexos equinocandina/hidrato de carbono | |
| BR0013353A (pt) | Combinação de substância ativa com clonidina | |
| EE03420B1 (et) | Farmatseutiline kompositsioon maania ja bipolaarse häire raviks | |
| BR0317095A (pt) | Uso de uma combinação contendo um inibidor da transcriptase reversa sem ser de nucleosìdeo (nnrti) com um inibidor citocromo p450, tal como inibidores da protease | |
| DE69217763D1 (de) | Hexapeptide | |
| ATE310513T1 (de) | Pharmazeutische zusammensetzung enthaltend den phospholipase inhibitor natrium ((3-(2-amino-1,2- dioxoethyl)-2-ethyl-1-phenylmethyl)-1 h-indol-4- yl)oxy)acetate | |
| EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
| AR036321A1 (es) | Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia. | |
| UA49789C2 (uk) | Застосування димеру лізоциму як лікарського засобу для інгібування біосинтезу фактора некрозу пухлини, спосіб лікування та профілактики захворювань (варіанти), фармацевтична композиція (варіанти), застосування димеру лізоциму як лікарського засобу для профілактики або лікування сніду | |
| UY26514A1 (es) | " composición para el tratamiento de tejidos danados". | |
| FI874123A0 (fi) | Heptanoyl-glu-asp-ala-aminosyra -immunostimulanter. | |
| BR0110628A (pt) | Uso de derivados de distamicina de acriloìla substituìda no tratamento de tumores associados a altos nìveis de glutationa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |